DITTO Raises $6 Million in Seed Funding
DITTO, a company focused on setting a new standard in menstrual health through advanced biotechnology and rigorous clinical trials, has successfully raised $6 million in a seed funding round. This round was led by FoodLabs, with participation from Eka Ventures.
Founders and Executive Team
The company was founded by Alice van der Schoot, with Adam Kugler serving as a co-founder. They have been at the forefront of developing innovative solutions in menstrual health, aiming to combine cutting-edge technology with high-level clinical research.
Strategic Investment by FoodLabs
FoodLabs, a prominent investor known for backing innovative health and wellness startups, led the funding round. The investment from FoodLabs, along with Eka Ventures, signifies strong confidence in DITTO's mission and potential.
Planned Use of Funds
While specific plans for the newly raised funds were not detailed, it is expected that the capital will be directed towards further development of DITTO's technology and expanding their market presence. These efforts will likely focus on enhancing their product offerings and potentially increasing their team to support growth.
The Future of Menstrual Health
With this funding, DITTO is well-positioned to advance its mission of improving menstrual health through innovative solutions. The company's approach, which integrates advanced biotechnology with high-standard clinical trials, sets it apart in the growing market for health tech solutions.
This seed round represents a significant step for DITTO as it continues to develop and bring to market new products that could transform the landscape of menstrual health care.